Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 1/2015

01-01-2015 | Editorial

Complex lipids

Authors: Jean-Marie Saudubray, Matthias R. Baumgartner, Ronald Wanders

Published in: Journal of Inherited Metabolic Disease | Issue 1/2015

Login to get access

Excerpt

In a review published in this journal in 2012, 14 inborn errors of metabolism (IEM) related to defects in biosynthesis and remodeling of phospholipids, sphingolipids and fatty acids were delineated and a new field was born (Lamari et al. 2013). Following the rapid expansion of this group of disorders and the elucidation of numerous cellular roles played by the affected molecules, a small group of IEM specialists met in Paris on June 14–15, 2013, to discuss the diagnostic approach and classification of IEM affecting the synthesis and remodeling of complex lipids. …
Literature
go back to reference Lamari F, Mochel F, Sedel F, Saudubray JM (2013) Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases. J Inherit Metab Dis 36(3):411–425PubMedCrossRef Lamari F, Mochel F, Sedel F, Saudubray JM (2013) Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases. J Inherit Metab Dis 36(3):411–425PubMedCrossRef
Metadata
Title
Complex lipids
Authors
Jean-Marie Saudubray
Matthias R. Baumgartner
Ronald Wanders
Publication date
01-01-2015
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 1/2015
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-014-9788-2

Other articles of this Issue 1/2015

Journal of Inherited Metabolic Disease 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.